Form 4: IN8BIO Director Alan S. Roemer Acquires Stock Options
SEC Form 4 Filing
Director Alan S. Roemer acquired stock options in IN8BIO, INC. on December 19, 2024.
Summary
- On December 19, 2024, Alan S. Roemer, a director of IN8BIO, INC., acquired 93,242 stock options with an exercise price of $0.24.
- These options vest on December 19, 2025, contingent upon continued service.
- Following the transaction, Roemer directly owns 93,242 derivative securities.
Sentiment
Score: 5
Explanation: Neutral sentiment as it's a standard disclosure of stock option acquisition. The director's action could be seen as a positive signal, but it's not definitive.
Positives
- The acquisition of stock options by a director may signal confidence in the company's future prospects.
Industry Context
Form 4 filings are standard disclosures required by the SEC to provide transparency regarding the transactions of company insiders. This filing indicates changes in beneficial ownership of IN8BIO's securities by a director.
Stakeholder Impact
- The acquisition of stock options by a director could positively influence shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 12/19/2024 | Date of the transaction: Alan S. Roemer acquired stock options. |
| 12/19/2025 | Vesting date for the stock options, contingent upon continued service. |
| 12/19/2034 | Expiration date for the stock options. |
| 12/23/2024 | Date of signature by Attorney-in-Fact. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.